Other Genodermatoses

Published on 05/03/2015 by admin

Last modified 22/04/2025

Print this page

This article have been viewed 3232 times

Other Genodermatoses

This chapter discusses genetic skin diseases that are not covered in other chapters, including conditions featuring extracutaneous tumorigenesis, enzyme deficiencies, premature aging, and ectodermal dysplasia.

Disorders Featuring Extracutaneous Tumorigenesis

Cowden Disease and Other Forms of PTEN Hamartoma Tumor Syndrome

• Spectrum of autosomal dominant multisystem disorders that feature characteristic skin findings (Fig. 52.1), macrocephaly, hamartomatous overgrowth of a variety of tissues, and a predisposition to certain cancers (Table 52.1).

Fig. 52.1 Cowden disease. A Multiple skin-colored papules on the face, especially the nose, some of which are verrucous. B Multiple palmar keratoses, many with a glassy appearance or depression centrally. A, Courtesy, Kalman Watsky, MD; B, Courtesy, Joyce Rico, MD.

Table 52.1

Major clinical manifestations of PTEN hamartoma tumor syndrome.

This categorization reflects general tendencies, as the age of onset or recognition of these findings can vary. Criteria for PTEN gene testing and guidelines for surveillance in patients suspected to have Cowden disease are available at http://www.nccn.org/professionals/physician_gls/PDF/genetics_screening.pdf.

^* Typically with fast-flow channels, intramuscular involvement, and ectopic fat; may have capillary, venous, and/or lymphatic components and associated soft tissue/bony overgrowth.

^† Hamartomatous dysplastic gangliocytoma of the cerebellum.

BRR, Bannayan–Riley–Ruvalcaba syndrome.

• Due to mutations in the phosphatase and tensin homolog tumor suppressor gene (PTEN), which negatively regulates the AKT/mammalian target of rapamycin (mTOR) pathway of increased cellular growth and survival.

Multiple Endocrine Neoplasia Syndromes

• Group of autosomal dominant disorders associated with neoplasia or hyperplasia in two or more endocrine organs, often presenting with mucocutaneous findings that serve as clues to the diagnosis (Table 52.2; Fig. 52.2).

Table 52.2

Classic multiple endocrine neoplasia (MEN) syndromes.

Fig. 52.2 Mucocutaneous findings in multiple endocrine neoplasia (MEN). A Multiple collagenomas in a patient with MEN type 1. B Enlarged nodular lips and multiple mucosal neuromas on the lateral and distal tongue in a patient with MEN type 2B. A, Courtesy, Susan Bayliss, MD.

Muir–Torre Syndrome (MTS)

• Subtype of hereditary nonpolyposis colorectal cancer (Lynch) syndrome characterized by sebaceous neoplasms (e.g. sebaceous adenoma, sebaceoma, sebaceous carcinoma; Fig. 52.3, see Table 91.2) and keratoacanthomas (± sebaceous differentiation) as well as internal malignancies (Table 52.3).

Fig. 52.3 Muir–Torre syndrome with multiple sebaceous neoplasms. Courtesy, Dan Ring, MD.

Table 52.3

Factors associated with a greater likelihood of Muir–Torre syndrome (MTS).

^* Testing can be performed on paraffin-embedded tissue; diagnostic yield may be higher for colonic lesions.

^** For example, other GI cancers (small bowel, gastric, biliary, pancreatic), genitourinary cancers (endometrial, bladder, ureteral, renal), and glioblastoma.

^† Sensitivity and specificity have varied and the overall utility is debated.

IHC, immunohistochemical; HNPCC, hereditary nonpolyposis colorectal cancer.

• Caused by heterozygous constitutional mutations in a DNA mismatch repair gene, e.g. MSH2 (~90% of patients), MLH1, and MSH6.

• Cutaneous findings develop at a mean age of ~55 years, presenting as yellow to pink papulonodules on the face (the usual site of sebaceous neoplasms outside of MTS) or trunk > extremities.

Enzyme Deficiency Disorders

Alkaptonuria

• Rare autosomal recessive disorder due to homogentisic acid oxidase deficiency.

• Urine that darkens on standing and brown-black cerumen represent early findings.

• Blue-gray discoloration of the axillary skin, ear (Fig. 52.4), and sclera typically appears during early adulthood, when arthritis and valvular heart disease often develop.

Fig. 52.4 Blue-gray discoloration of the pinna in a woman with alkaptonuria. Courtesy, Julie V. Schaffer, MD.

Fabry Disease

• X-linked lysosomal storage disorder due to α-galactosidase A deficiency, which leads to glycosphingolipid accumulation within endothelial cells and results in progressive renal, coronary, and cerebrovascular insufficiency.

• Female heterozygotes have variable clinical manifestations, often with later onset than those in affected men.

• Angiokeratoma corporis diffusum presents as punctate dark red macules and papules clustered between the umbilicus and knees (‘bathing trunk’ distribution); serves as an early sign of Fabry disease, typically developing in childhood or adolescence along with paresthesias of the extremities, hypohidrosis, and whorled corneal opacities.

• Fig. 52.5 compares the clinical features of Fabry disease and fucosidosis, one of several other lysosomal storage disorders associated with angiokeratomas.

Fig. 52.5 Clinical features of Fabry disease and fucosidosis. *Also lenticular in Fabry disease. **Milder in Fabry disease. ^§Occasionally observed in fucosidosis. Angiokeratomas of Fabry disease, courtesy, Julie V. Schaffer, MD; photomicrograph of urinary sediment demonstrating Maltese crosses (via polarization), courtesy, Robert J. Desnick, MD, PhD.

• Rx: intravenous α-galactosidase A replacement therapy.

Phenylketonuria

• Autosomal recessive disorder due to phenylalanine hydroxylase deficiency.

• Cutaneous findings can include diffuse pigmentary dilution (skin, hair, eyes), eczematous dermatitis, sclerodermatous skin changes favoring the proximal extremities (Fig. 52.6), and sweat with a musty odor; pigmentary banding of the hair can occur as a reflection of nonadherence to the diet.

Fig. 52.6 Phenylketonuria (PKU). Infant with PKU and sclerodermoid skin changes. Courtesy, New York Medical College.

• Newborn screening allows prevention of mental retardation and skin changes through early nutritional intervention (e.g. a phenylalanine-restricted diet).

Mitochondrial Disorders

• This heterogeneous group of conditions can present with a wide variety of cutaneous manifestations (Table 52.4) as well as neuromuscular and visceral dysfunction.

Table 52.4

Cutaneous manifestations of mitochondrial respiratory chain disorders.

Premature Aging Disorders

Hutchinson–Gilford Progeria Syndrome

• Accelerated aging due to heterozygous mutations in the LMNA gene; the mutant lamin A protein (‘progerin’) remains farnesylated and disrupts nuclear scaffolding.

• Onset during infancy of growth failure, facial findings (e.g. frontal bossing, protruding eyes, prominent veins), decreased subcutaneous fat, and cutaneous manifestations such as thin dry skin, acral wrinkling, mottled hyperpigmentation, sclerodermoid changes (especially on the lower trunk and thighs), and alopecia.

• Progressive atherosclerosis results in a median life span of 12 years.

• Rx: inhibitors of farnesylation and related processes may be of benefit.

Werner Syndrome

• Autosomal recessive disorder characterized by premature aging beginning in the second decade of life; caused by mutations in the RECQL2 gene, which encodes a DNA helicase.

• Cutaneous findings include atrophy, mottled hyperpigmentation, sclerodermoid changes, keratoses and ulcers over pressure points (especially acrally), and premature graying of hair.

• Short stature, characteristic facies (e.g. thin with beaked nose; Fig. 52.7), atherosclerosis, osteoporosis, diabetes mellitus, and an increased risk of sarcomas are additional features; median survival ~50 years.

Fig. 52.7 Werner syndrome. Characteristic features include a beaked nose, tautness of the skin, prominent veins, and micrognathia. Courtesy, Ronald P. Rapini, MD.

Ectodermal Dysplasias

• Large, heterogeneous group of genetic disorders characterized by abnormalities in ≥2 major ectodermal structures (hair, sweat glands, nails, teeth); other ectodermal structures (e.g. sebaceous or mucous glands) may also be affected.

• Major features of several classic forms of ectodermal dysplasia are presented in Table 52.5 and Figs. 52.8–52.11.

Table 52.5

Selected ectodermal dysplasia (ED) syndromes.

^* Variable phenotype with mosaic pattern (e.g. hypohidrosis and hyperpigmentation along Blaschko’s lines) in female ‘carriers’ of XLR form.

^** Female carriers may have mild features of incontinentia pigmenti (see Chapter 51).

^† Includes odonto-onycho-dermal dysplasia and Schöpf–Schulz–Passarge syndrome, which also features eyelid hidrocystomas.

^‡ Rapp–Hodgkin syndrome is now included in the AEC spectrum.

AD, autosomal dominant; AEC, ankyloblepharon-ED-clefting; AR, autosomal recessive; EDA, ectodysplasin A; EDAR, EDA receptor; EDARADD, EDAR-associated death domain; EEC, ED-ectrodactyly-clefting; ESFA, eccrine syringofibroadenomatosis; GER, gastroesophageal reflux; GJB6, gap junction β6 (encodes connexin 30); NEMO, NF-κB essential modulator; NFKBIA, NF-κB inhibitor-α; PPK, palmoplantar keratoderma; XLR, X-linked recessive.